The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have determined that respirators that meet the regulatory requirements of the countries listed in the FDA’s Emergency Use Authorization (EUA) may be appropriate to protect workers during the pandemic. However, due to the current demand, buyers should be aware that there are an unprecedented number of products on the market that do not perform as advertised. This webinar will discuss the common pitfalls of purchasing respirators internationally to assist buyers to make informed procurement decisions to keep their workers safe. The considerations presented in this webinar will help to maximize the likelihood of obtaining safe and effective products. See the NIOSH webpage for more information about the webinar, including the panel of speakers.